Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Movmedix is a global leader in artificial ligament technology, with over 150,000 implantations worldwide and more than 30 years of clinical use. Their products enable rapid recovery for patients—especially athletes—by providing alternatives to autograft/allograft techniques, reducing morbidity and infection risks. The company reported over €8.5 million in sales in 2021 with a growth rate exceeding 60%.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Movmedix.